Produced in partnership with the Asthma and Allergy Foundation of America (AAFA)
This patient education program is supported by a sponsorship from Genentech, a member of the Roche Group.
Patients with chronic spontaneous urticaria, or CSU, often feel powerless to combat the hives and painful swelling that can affect their appearance and the quality of their lives. Getting a diagnosis can be hard and, even with a diagnosis, commonly used treatments may provide little or no relief.
There is a way to get some help. Patients and caregivers need to stay informed of recommended and newer treatments. Doing this allows them to communicate effectively with their doctors and other healthcare providers. Patients can help select treatments that work best for them. Want to learn how? Join us for a live webinar on Monday, March 27, at 4:00 PM ET featuring a doctor, a patient advocacy representative, and a patient with CSU who will discuss the latest information about CSU from causes to treatments.
- Understand that chronic spontaneous urticaria, or CSU, affects only the skin, hives may disappear over time, and usually no specific cause can be identified
- Engage with your health care provider to obtain appropriate treatments with prompt dose increases
- Understand when you may qualify for a biologic treatment
Other topics that will be discussed include:
- Types of urticaria
- Difficulty diagnosing
- First-line treatment options
- Signs that you should change treatment
- Biologics and how they affect CSU
- The role of T2 inflammation
- Positioning and role of TSLP
The panel will answer questions from the audience during the live session. You can send in your questions ahead of time by clicking here.
Register now to watch the event live or later on-demand.
Luz Fonacier, MD
Professor of Medicine
NYU Long Island School of Medicine
Head of Allergy and Training Program Director
NYU Langone Health-Long Island
Public Health Manager
Patient with Chronic Autoimmune Urticaria